Latest Breaking News On - Projected sales - Page 1 : comparemela.com

(Reuters) -Biogen on Tuesday forecast flat 2024 product revenue as top-selling drugs face tough competition and sales of newer treatments take off slowly, but said there are signs its new Alzheimer's drug is gaining traction. Shares of the U.S. biotech fell 7% as it missed Wall Street expectations for quarterly revenue and projected sales for this year that several analysts found underwhelming. Sales of pricey spinal muscular atrophy drug Spinraza, which is dealing with fresh competition, also missed estimates.

United statesShounak dasguptaSriparna royManas mishraChristopher viehbacherWall streetBill berkrotProjected salesEw alzheimer 39s drugMissed estimatesChristopher viehbacher